The short version
13 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
diclofenac epolamine
diclofenac epolamine · DICLOFENAC EPOLAMINE .013 g/1 · System · Topical · Quality Care Products, LLC
NDC 83008-0036-30 · 6 POUCH in 1 CARTON / 5 SYSTEM in 1 POUCH · NDA AUTHORIZED GENERIC · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 00093-3727-55) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$11.35per unit
middle half $11.26–$11.45 · 295 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $11.35
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
5%of plans cover it
tier 4 · prior auth 77% · step therapy 0% · qty limit 80%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 1 quarter since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for diclofenac epolamine (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- relabel
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA021234
- TE code
- —
- Approval date
- Jan 31, 2007
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of diclofenac epolamine (System)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| IBSA Pharma Inc. | DICLOFENAC EPOLAMINE .013 g/1 | Jul 15, 2026 | Sep 3, 2026 |
| Sportpharm LLC | DICLOFENAC EPOLAMINE .013 g/1 | Aug 27, 2026 | Sep 3, 2026 |
| Advanced Rx of Tennessee, LLC | DICLOFENAC EPOLAMINE .013 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Advanced Rx Pharmacy of Tennessee, LLC | DICLOFENAC EPOLAMINE .013 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Asclemed Usa Inc. | DICLOFENAC EPOLAMINE .013 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Asclemed USA, Inc. | DICLOFENAC EPOLAMINE .013 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Hawaii Repack, Inc. | DICLOFENAC EPOLAMINE .013 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Phoenix RX LLC | DICLOFENAC EPOLAMINE .013 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals Inc. | DICLOFENAC EPOLAMINE .013 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Quality Care Products, LLC | DICLOFENAC EPOLAMINE .013 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teikoku Seiyaku Co., Ltd. | DICLOFENAC EPOLAMINE .013 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA Inc. | DICLOFENAC EPOLAMINE .013 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| YARAL Pharma Inc. | DICLOFENAC EPOLAMINE .013 g/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "diclofenac epolamine — NDC 83008-0036-30," retrieved September 3, 2026, https://drugdashboards.com/drug/83008003630.
Free to cite with attribution — see how the data is put together.